The underlying mechanism was that p65 and pSTAT3 formed a p65/pSTAT3 complex, occupied the pSTAT3-binding site on the G6PD promoter, synergistically facilitated G6PD overexpression, and contributed to ccRCC proliferation. Here, G6PD is linked to nonpapillary renal cell carcinoma.